EP Patent

EP4208468A4 — Radiolabeling and formulation for scale up of 64cu-dotatate

Assigned to Curium US LLC · Expires 2024-09-18 · 2y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: EP4208468A4
Jurisdiction: EP
Classification: —
Expires: 2024-09-18
Drug substance claim: No
Drug product claim: No
Assignee: Curium US LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.